To determine the normal relationship in vivo between action potential duration (APD) and effective refractory period (ERP) over a large range of steady-state cycle lengths (CLs) and to determine how a sodium channel-blocking agent, quinidine, affects this relationship, we developed a new contact electrode technique for simultaneous measurements of monophasic action potentials and refractoriness at a single site in the beating heart in situ. Recordings were made from left ventricular epicardium in open-chest dogs during steady-state pacing at CLs from 220 to 600 msec both before and after therapeutic intravenous administration of quinidine. During baseline both APD at 90% repolarization (APD90) and ERP were linearly correlated to CL with nearly identical slopes: y = 0.24x CL+83.0 (r-'1.0; p<.0001) for APD90 and y=0.22x CL+82.3 (r=1.0; p<.0001) for ERP.
frequency dependent, and may be manifested progressively more with higher heart rates.7' [9] [10] [11] [12] Experimental data on ventricular repolarization, refractoriness, and antiarrhythmic drug effects stem almost exclusively from isolated, artificially superfused preparations in which intracellular potentials can be measured simultaneously with stimulation threshold in single cardiac cells. Such measurements have not yet been duplicated in vivo because it has not been possible to record both APD and ERP at the same time and the same site in a beating heart. We therefore developed a new, single-bipolar contact electrode technique that permits simultaneous recording of monophasic action potentials (MAPs) simultaneously with ERP determinations at the same ventricular site in the beating heart in situ.
The first objective of this study was to determine the normal relationship between ERP and APD in the canine ventricle in situ over a large range of steady-state cycle lengths (CLs). The second objective was to exam-ine the effect of a sodium channel-blocking drug, quinidine, on the relationship between APD and ERP and to determine whether this relationship is modified by the frequency of stimulation.
Methods
Twenty-one mongrel dogs weighing 10 to 30 kg were anesthetized with a combination of intravenous urethane (625 mg/kg) and ot-chloralose (80 mg/kg). The animals were intubated and ventilated with humidified room air by a Harvard model 613 respirator with adjustment based on arterial blood gases (Corning 165 pH/blood gas analyzer) measured every 30 min to maintain oxygen tension greater than 85 mm Hg and pH between 7.35 and 7.45. A polyethylene catheter was placed in the femoral artery and connected to a Statham fluid-filled pressure transducer. Mean arterial blood pressure was displayed continuously on a Beckman Instruments oscilloscope and remained stable above 80 mm Hg throughout the experimental protocol. A polyethylene catheter inserted into a femoral vein was used for the intravenous infusion of quinidine. Hearts were exposed through a left thoracotomy and suspended in a pericardial cradle. MAP recordings. MAPs were recorded from the left ventricular epicardium with a contact electrode probe, as described earlier. ' 3 This technique has been validated by quantitative comparison with simultaneous intracellular recordings of action potentials.'4 In brief, the MAP recording probe consists of an L-shaped cantilever with two Ag-AgCl electrodes mounted on its distal end (figure 1). The "exploring" electrode at the tip of the probe is 1 mm in diameter and embedded in a thin collar of epoxy cement. The reference electrode is located along the probe shaft 5 mm proximal from the tip. A spring-loaded mechanism built into the shaft of the cantilever provides continuous contact of the tip electrode with the epicardial surface of the beating heart. A soft piece of cylindrically shaped foam rubber soaked with 0.9% saline solution is mounted over the distal end of the probe, covering the proximal electrode and reaching to the tip, where it forms a 1 mm thick anulus around the tip electrode. This foam rubber serves as a small volume conductor that establishes electrical continuity between the tip and reference electrode and between the reference electrode and the epicardium. The probe handle is mounted at the table and positioned so that the tip electrode rests stably on either the anterior or lateral surface of the left ventricle. Once the probe is positioned with the tip exerting a contact pressure of approximately 30 g, MAPs of stable amplitude and waveform can be recorded continuously over long time periods (hours).
The MAP signals were recorded with high input impedance, direct-current coupled, differential amplifiers (Grass Instru-2mm FIGURE 1. Schematic representation of contact electrode probe and electrical circuit used for simultaneous MAP recordings and determination of refractoriness at a single epicardial site. See text for details. ments, Model P 16) along with 3 surface electrocardiographic (ECG) tracings1-3 recorded with conventional ECG amplifiers and written out by multichannel electrostatic recorder (Gould ES 1000) at a paper speed of 250 mm/sec. The frequency response of the recording system was 0 to 5000 Hz and the accuracy of measurements of the ADP at 90% repolarization (APD90) was better than 2 msec, as assessed by two independent observers.
Refractory period determination at the recording site (figure 2). Hearts were driven with basic stimuli through a pair of needle electrodes placed in the right ventricular free wall. Extrastimuli of 1 msec duration and twice diastolic threshold strength were generated by a second stimulator and applied to the left ventricle through the MAP recording electrodes ( figure   1 ). Although this resulted in a large stimulus artifact in the MAP recordings (mainly due to polarization of the Ag-AgC1 electrodes), it generally did not prevent the recognition of whether the extrastimulus provoked a new propagated response (figure 2, compare response in A to that in B). If polarization was so large as to drive the MAP tracing completely off-screen, propagated depolarization of the ventricle was verified by an appropriately timed premature and aberrantly conducted beat in the surface electrocardiogram ( figure 2, B ). The extrastimulus current strength was measured as the voltage drop across a series 10 Q resistor; this low resistor value was appropriate because the Ag-AgCl electrodes had a source impedance of only 10 to 80 Q.
Extrastimulus thresholds were tested during late diastole at each steady-state CL, both before and after quinidine administration, and if necessary, the stimulus strength was adjusted to twice threshold.
Starting in late diastole, the extrastimulus coupling interval was shortened in 5 msec decrements until refractoriness occurred. Each ERP determination was made in the steady-state and repeated to ensure reproducibility. Because the basic drive stimuli were applied to the right ventricle and the extrastimulus was applied to the left ventricle, the basic-to-extrastimulus interval included the interventricular conduction time, which may vary with sudden interval changes. The local ERP was therefore determined as the interval from the MAP upstroke of the last steady-state response to the extrastimulus that just failed to elicit a new response. Figure 2 gives an example of how the local left ventricular epicardial ERP was determined simultaneously with the MAP duration. As shown in figure 2 ,A, a stimulus delivered 190 msec after the MAP upstroke elicited a propagated response, as appreciated by a subsequent MAP signal and a premature and altered QRS complex. As shown in figure 2 , B, a stimulus of identical current strength delivered 5 msec earlier (at 185 msec) failed to elicit a propagated response; this interval was the ERP that was compared with the duration of the preceding steady state MAP. APD90 was measured from the MAP upstroke to the time of 90% repolarization according to the methods described earlier.14 ERP was compared with APD90 recorded at the same site; for the purpose of this study, postrepolarization refractoriness was defined as an ERP greater than APD90. To further define the relationship between membrane repolarization and refractoriness, the repolarization level (in percent of total MAP amplitude) at which excitability recurred was also measured.
Effect of dilferent steady-state CLs. Pacingwas begun at the longest basic drive CL able to overdrive the spontaneous heart rate (usually 600 msec) and maintained constant for 2 minuntil a steady state was reached. The basic CL was then decreased in steps of 50 msec, each step being maintained for at least 2 min to ensure steady state. ERP and APD90 measurements were made with an extrastimulus introduced every 12 cycles without ensuing pause. The longest overdrive CL for statistical purposes was 600 msec in the 21 control dogs and 500 msec in the nine dogs treated with quinidine (sinus nodes were not crushed). The shortest steady-state CL studied was 220 msec.
Effect of quinidine on APD90 and ERP. After baseline determination of APD90 and ERP, quinidine gluconate was administered as a bolus of 3.85 mg/kg over 1 min, followed by a constant infusion of 0.28 mg/kg/min.'5 Measurements were resumed with the MAP electrode maintained at the same epicardial site after an equilibration period of 30 min. Blood samples for determination of quinidine serum concentration (American Bioscience Laboratories) were drawn 30 and 90 min after the infusion was begun. Average quinidine plasma concentrations at 30 and 90 min were 3.3+0.5 and 3.2+0.7 ,ug/ml, respectively. Two of 11 animals had drug levels below the predefined therapeutic range (2.0 to 5.0 ,ug/ml) at either 30 or 90 min and their data were excluded from analysis.
Statistical evaluation of results. APD90 determinations were averaged over the last five responses preceding each extrastimulation at the end of a train of regular pacing and compared with the average of two consecutive ERP determinations at steady state. The relationship of APD90 and ERP to CL and the significance of this relationship were evaluated by simple linear regression analysis, with confidence intervals set at 95%. The significance of drug effect and frequency dependence of APD90 and ERP were evaluated by two-factorial analysis of variance for repeated measures with an F test for interaction. Group data are presented as the mean + SEM.
Results
MAPs could be recorded continuously from the same epicardial site throughout the entire study protocol (up to 4 hr). Throughout this time period and despite the continuous contact pressure exerted by the tip electrode against the epicardium, the MAP recordings and pacing thresholds remained highly reproducible. After an initial stabilization period of 5 min, the MAP amplitude did not change by more than 20% for the subsequent investigational period of up to 4 hr. The duration of the MAP at 90% repolarization (APD9O) varied by no more than 5 msec (2%) and the ERP was constant within the 5 msec limit of resolution under baseline conditions (steady-state pacing in the drug-free state) for test periods of 1 hr and more. Tdenotes the artifact of the basic drive stimulus deliv-1 i 20 mV ered to the right ventricle. CT is the interventricular conduction time from the right ventricular stimulus site to the left ventricular recording site. In A, an extrastimulus (S2) of two times diastolic threshold strength applied 190 msec after the onset of the previous depolarization through the MAP recording electrodes produces a marked stimulus artifact and elicits a new response; both a local MAP recording and a propagated ECG ventricular response are seen. In B, a stimulus of identical strength applied 5 msec earlier produces only a stimulus artifact without local or propagated ventricular response. This interval (185 msec in this example) was the local ERP.
Threshold current strengths at end-diastole were 0.13 ± 0.02 mA (n = 10) over the entire range of basic CLs before quinidine and 0.25 + 0.06 mA (n = 6) after quinidine at steady-state CLs longer than 500 msec. With CLs shorter than 400 msec, further increases in diastolic threshold were sometimes observed in the quinidine-treated dogs, and stimulus strength was adjusted accordingly.
Relationship of APD90 and ERP to steady-state CL under control conditions. Figure 3 demonstrates the CL dependence of both APD90 and ERP in 21 attendant change in APD90 at all CLs. On average, the ERP was 11 + 3 msec shorter than APD90. At CLs above 600 msec, both APD90 and ERP increased relatively less, thus deviating from the linear relationship with CL.
As shown schematically in figure 4 , inset, frequency-dependent changes in APD90 were due to a change in plateau duration, while the slope of phase 3 remained unaltered. A linear relationship between APD90 and ERP might then indicate that excitability recurred always at a similar repolarization level. This was directly evaluated in nine experiments by expressing the ERP as a function of percent repolarization. As shown in figure 4 , recovery from refractoriness occurred over a narrow range of repolarization levels (79% to 83%), and this range was independent of CL.
Effect of quinidine on APD90 and ERP at different steadystate CLs. Quinidine increased APD90 uniformly over the entire range of steady-state CLs studied (figure 5, A). For instance, at steady-state CLs of 250, 350, 450, and 550 msec APD90 after quinidine was an average of 11 + 3, 10 ± 2, 10 + 3, and 12 + 7 msec, respectively, longer than control. Thus, the action potentialprolonging effect of quinidine was not significantly influenced by the CL.
In contrast, the effect of quinidine on ERP was strongly CL dependent ( figure 5, B) . At relatively long CLs of 400 to 500 msec, quinidine prolonged the ERP by only 19 to 22 msec (which is only slightly longer than the concomitant increase in APD9O). However, at shorter steady-state CLs, quinidine caused progressively greater increases in ERP of up to 61 + 21 msec at a CL of 220 msec.
An increase in ERP that is not accounted for by an identical increase in APD90 represents a shift in the normal relationship between repolarization and refractoriness, also known as postrepolarization refractoriness. Figure 6 depicts the amount of postrepolarization refractoriness, obtained by subtracting APD90 from ERP, as a function of steady-state CL. In the absence of drug, the ERP-APD90 difference is negative (because the ERP is shorter than the APD9O) and insensitive to CL. In the presence of quinidine and at a CL of 500 msec, ERP is only 9 + 3 msec longer than APD90. With decreasing steady-state CL, ERP progressively increases relative to APD90 until at a CL of 220 ship between APD and CL also has been observed,23 and this variance may be related to species differences ussion and/or a different range of CLs studied, as well as to ethodologic considerations. This study demonstrates nonsteady-state conditions.24 reliable stimulation of the ventricle in situ is pos-Refractory periods in isolated1' 2 or in vivo ventricwith an electrode that rests on the myocardial ular muscle25 also shorten with a decrease in CL, but Lce with slight pressure and that allows recording this relationship has in general not been explored over APs from the same site. Stimulus thresholds at a a large range of steady-state CLs. Furthermore, these epicardial site were highly reproducible over earlier studies did not determine APD and ERP al hours and were low in comparison with those together, and therefore allow no conclusion as to ig endocardial pacing with the use of conventional whether the slope of the cycle-length relationship of rode catheters. 16 This, and the high stability of the APD was identical to that of ERP and to what extent amplitude and waveform, make it unlikely that the ERP-APD relationship was affected by antiarrhythbersistent contact pressure exerted against the epimic drugs. The present study demonstrates for the heart ium results in significant myocardial damage.
in vivo that the recovery of excitability occurs over a discussed in detail previously,13' 14, 17the contact narrow, fixed range of membrane repolarization that, rode pressure probably depolarizes and renders in the drug-free state, is not affected by heart rate. :itable the cells subjacent to the electrode tip; these Effect of quinidine on APD90 at different CLs. Previous then provide a constant reference against which studies in vitro on the effect of quinidine on APD have Lctive depolarizations and repolarizations of the produced variable results. In some studies quinidine 'unding normal cells are measured. Previous stud-prolonged the APD in Purkinje fibers and ventricular uggest that the MAPs recorded by this method muscle in a dose-dependent fashion,7' 26-28 and in othsents the electrical activity of a group of cells in ers APD was not changed9 or was even shortened after proximity to the contact electrode tip. 13 14 The quinidine.29 30 Most preparations in vitro were driven ively low stimulus threshold in this study also at CLs above the physiologic range of the respective ests that excitable cells exist within close reach of species, and in studies in which the effect of quinidine timulating (and recording) electrode. Thus, it is on APD was measured over several CLs, the APD- 7, 28, 31, 32 y that the group of cells whose refractoriness was prolonging effect was attenuated at high rates. )red overlapped closely with the group of cells It is difficult to reconcile these differences in quinidine-;e repolarization time course was examined.
induced effects on APD, because the widely varying te necessity to analyze the relationship between experimental conditions, species and fiber types invesand ERP at the same myocardial site has been tigated, electrolyte compositions, and pacing protocols hasized by recent studies that showed that both all may modulate quinidine's effect on APD. In this 0 0) U) E 0ã :
Cc: l study in vivo, therapeutic quinidine concentrations produced a small but significant increase in APD90 of epicardial muscle that was uniform over a physiologic range of CLs.
Quinidine eifect on ERP at diiferent CLs. Previously reported effects of quinidine on ERP are more consistent. Both in vitro and clinical studies generally have demonstrated an increase in ERP after quinidine,7' 8, 27, 33 but the quantitative relationship to attendant changes in APD has not been explored in vivo. In those studies in vitro in which APD and ERP were measured simultaneously, the effect of quinidine was determined at a single, usually very long, CL. For instance, Varro et al."1 found that at a drive CL of 500 msec quinidine-induced prolongation of ERP exceeded that of APD by an average 5%. We also noticed only a small increase in postrepolarization refractoriness after quinidine when the hearts were paced at long CLs (500 to 600 msec). However, when the CL was decreased, ERP shortened less than APD90, resulting in a progressive increase in the magnitude of quinidineinduced postrepolarization refractoriness. Chen et al. 34 have shown previously in isolated preparations that quinidine does not influence the normal relationship between membrane voltage and membrane responsiveness at long cycle lengths. In contrast, significant effects of quinidine on membrane excitability and refractoriness were observed at higher stimulation frequencies.7 3 Our findings corroborate the frequency dependence of quinidine's effect for the canine ventricle in situ.
Significance of postrepolarization refractoriness. Frequency dependence of antiarrhythmic drug effects recently has received growing attention, primarily for two reasons. First, as pointed out by Harrison,5 frequency dependency shows good correspondence with current subclassifications of class I antiarrhythmic agents and may provide a more scientific basis for such classifications. Second, the phenomenon of frequency dependence appears to be a useful tool for analyzing the kinetics of drug-induced depression of the sodium channel. Based on the frequency-dependence of antiarrhythmic drug effect, Hondeghem and Katzung36 advanced the modulated receptor hypothesis, which helps explain and characterize the interference of antiarrhythmic drugs with the sodium channel. According to this model, drug binding occurs much more avidly during the depolarized state, and the time course with which the block disappears is a function of the drug's dissociation kinetics and membrane potential. In essence, a drug with relatively slow dissociation from the sodium channel exhibits greater cumulative effect at high heart rates than a drug with faster dissociation kinetics, and a given drug produces greater suppression of excitability at high heart rates than at low heart rates.
Sodium-channel block ordinarily is quantified by a decrease in sodium current, INa, or the maximum upstroke velocity, Vmax, of the transmembrane action potential. These variables, however, cannot be measured in vivo. This limitation includes, at present, even MAP recordings; although these have been shown to reliably indicate transmembrane action potential duration, they have not yet been validated as an index of transmembrane Vm.X. To identify frequency-dependent effects of antiarrhythmic drugs in vivo, or even in the clinical setting, several alternative electrophysiologic variables have been used. Davis et al.37 measured His-bundle conduction time (HV) in dogs and found that lidocaine increased HV in a frequency-dependent fashion that showed good agreement with data previously determined in vitro by use of Vmax. His-bundle pacing, however, is difficult in patients. Morady et al. 38 evaluated frequency-dependent effects of antiarrhythmic drugs in patients with the use of QRS duration, and Duff et al.33 measured conduction times between two distinct right ventricular sites as an indirect index of sodium-channel excitability. However, intraventricular conduction times and QRS duration are reliable estimates of conduction velocity only as long as the propagation pathway remains constant, and conduction velocity is a reliable estimate of transmembrane Vmax only as long as other variables determining conduction velocity, such as changes in the degree of intercellular coupling, can be controlled.39 It seems difficult to rule out these influences in the beating heart in situ. In addition, measurements of QRS duration lack precision and reliability, particularly at high heart rates.
The frequency dependence of quinidine-induced postrepolarization refractoriness in this study had a time course very similar to that previously described for Vmax in isolated ventricular muscle.40 Although not directly equatable, both indexes reflect the degree of recovery from inactivation of the sodium channel and share the property of frequency dependence. Further studies are needed to determine the cellular mechanism of drug-induced, frequency-dependent postrepolarization refractoriness and its quantitative relationship to changes in sodium-channel conductance.
Clinical implications. With the use of the recently introduced contact electrode catheter, stable continuous MAPs can be recorded from the human endocardium over long time periods.17 Preliminary studies41 have shown that simultaneous determinations of APD and ERP are possible, and it will be of interest to determine the relationship between repolarization and refractoriness, and the effect of rate and antiarrhythmic drugs on this relationship, in clinical studies. This could provide a new tool for the quantification and characterization of the effects of sodium channelblocking agents in patients and, as recently suggested by Hondeghem,42 may aid in tailoring a specific antiarrhythmic drug regimen to an individual patient.
Our results on the rate dependence of quinidine's effect on refractoriness may also apply to certain clinical observations. Electropharmacologic studies usually assess the efficacy of an antiarrhythmic agent by observing the inducibility of ventricular tachycardia by extrastimuli that are delivered after a previous train of relatively rapid pacing. A drug with relatively slow dissociation kinetics (such as quinidine) would be expected to increase refractoriness relative to APD and thus exert a protective effect against extrastimulation. Our method would allow the determination of whether, and to what extent, drug efficacy during programmed electrical stimulation is indeed related to the presence of such a "window" of refractoriness that extends beyond myocardial repolarization. Outside the electrophysiology laboratory, the patient's (slower) sinus rhythm may allow initiation of ventricular tachycardia by a single premature beat because the efficacy of the prescribed agent may depend on a sufficiently high heart rate. This may explain in part the divergence between electropharmacologic test responses and clinical follow-up. The same rationale may apply to the beneficial effect of overdrive pacing used in the management of drug-induced arrhythmias, such as torsade de pointes.
